Cao Yuan, Diao Wei, Tian Fangfang, Zhang Feifei, He Laichang, Long Xipeng, Zhou Fuqinq, Jia Zhiyun
Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, 610041, China.
Neuropsychol Rev. 2021 Dec;31(4):703-720. doi: 10.1007/s11065-021-09479-3. Epub 2021 Feb 13.
Gray matter atrophy in multiple sclerosis (MS) is thought to be associated with disability and cognitive impairment, but previous studies have sometimes had discordant results, and the atrophy patterns of relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS) remain to be clarified. We conducted a meta-analysis using anisotropic effect-size-based algorithms (AES-SDM) to identify consistent findings from whole-brain voxel-based morphometry (VBM) studies of gray matter volume (GMV) in 924 RRMS patients and 204 PPMS patients. This study is registered with PROSPERO (number CRD42019121319). Compared with healthy controls, RRMS and PPMS patients showed gray matter atrophy in the cortico-striatal-thalamic network, sensorimotor network, and bilateral insula. RRMS patients had a larger GMV in the left insula, cerebellum, right precentral gyrus, and bilateral putamen as well as a smaller GMV in the bilateral cingulate, caudate nucleus, right thalamus, superior temporal gyrus and left postcentral gyrus than PPMS patients. The disease duration, Expanded Disability Status Scale score, Paced Auditory Serial Addition Test z-score, and T2-weighted lesion load were associated with specific gray matter regions in RRMS or PPMS. Alterations in the cortico-striatal-thalamic networks, sensorimotor network, and insula may be involved in the common pathogenesis of RRMS and PPMS. The deficits in the cingulate gyrus and caudate nucleus are more apparent in RRMS than in PPMS. The more severe cerebellum atrophy in PPMS may be a brain feature associated with its neurological manifestations. These imaging biomarkers provide morphological evidence for the pathophysiology of MS and should be verified in future research.
多发性硬化症(MS)中的灰质萎缩被认为与残疾和认知障碍有关,但以往的研究结果有时并不一致,复发缓解型多发性硬化症(RRMS)和原发性进展型多发性硬化症(PPMS)的萎缩模式仍有待阐明。我们使用基于各向异性效应量的算法(AES-SDM)进行了一项荟萃分析,以从924例RRMS患者和204例PPMS患者的全脑基于体素的形态测量(VBM)研究中确定灰质体积(GMV)的一致发现。本研究已在PROSPERO注册(编号CRD42019121319)。与健康对照相比,RRMS和PPMS患者在皮质-纹状体-丘脑网络、感觉运动网络和双侧岛叶出现灰质萎缩。与PPMS患者相比,RRMS患者左侧岛叶、小脑、右侧中央前回和双侧壳核的GMV较大,而双侧扣带回、尾状核、右侧丘脑、颞上回和左侧中央后回的GMV较小。疾病持续时间、扩展残疾状态量表评分、听觉序列加法测试z评分和T2加权病变负荷与RRMS或PPMS中的特定灰质区域相关。皮质-纹状体-丘脑网络、感觉运动网络和岛叶的改变可能参与RRMS和PPMS的共同发病机制。扣带回和尾状核的缺陷在RRMS中比在PPMS中更明显。PPMS中更严重的小脑萎缩可能是与其神经学表现相关的脑特征。这些影像学生物标志物为MS的病理生理学提供了形态学证据,应在未来的研究中进行验证。